Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chris Kingswood

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Kidney International|August 26, 2004
Renal angiomyolipomataJohn J Bissler, J Chris Kingswood
Nephron|August 10, 2016
Review of the Tuberous Sclerosis Renal Guidelines from the 2012 Consensus Conference: Current Data and Future StudyJ Chris Kingswood, John J Bissler, Klemens Budde, et al.
Plos One|August 10, 2017
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 studyJohn J Bissler, J Chris Kingswood, Elzbieta Radzikowska, et al.
The New England Journal of Medicine|January 11, 2008
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosisD Mark Davies, Simon R Johnson, Anne E Tattersfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2011
Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trialD Mark Davies, Petrus J de Vries, Simon R Johnson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2014
The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1J Chris Kingswood, Sergiusz Jozwiak, Elena D Belousova, et al.
Frontiers in Neurology|November 30, 2019
Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated CareNicholas M P Annear, Richard E Appleton, Zahabiyah Bassi, et al.
Journal of Neurodevelopmental Disorders|September 14, 2023
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)Petrus J de Vries, Tosca-Marie Heunis, Stephanie Vanclooster, et al.
Orphanet Journal of Rare Diseases|June 13, 2025
Validation of the self-report quantified Tuberous Sclerosis Complex-Associated Neuropsyciatric Disorders Checklist (TAND-SQ)Nola Chambers, Tosca-Marie Heunis, Sugnet Gardner-Lubbe, et al.
Orphanet Journal of Rare Diseases|July 7, 2021
Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)Matthias Sauter, Elena Belousova, Mirjana P Benedik, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Kidney International|August 26, 2004
Renal angiomyolipomataJohn J Bissler, J Chris Kingswood
Nephron|August 10, 2016
Review of the Tuberous Sclerosis Renal Guidelines from the 2012 Consensus Conference: Current Data and Future StudyJ Chris Kingswood, John J Bissler, Klemens Budde, et al.
Plos One|August 10, 2017
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 studyJohn J Bissler, J Chris Kingswood, Elzbieta Radzikowska, et al.
The New England Journal of Medicine|January 11, 2008
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosisD Mark Davies, Simon R Johnson, Anne E Tattersfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2011
Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trialD Mark Davies, Petrus J de Vries, Simon R Johnson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2014
The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1J Chris Kingswood, Sergiusz Jozwiak, Elena D Belousova, et al.
Frontiers in Neurology|November 30, 2019
Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated CareNicholas M P Annear, Richard E Appleton, Zahabiyah Bassi, et al.
Journal of Neurodevelopmental Disorders|September 14, 2023
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)Petrus J de Vries, Tosca-Marie Heunis, Stephanie Vanclooster, et al.
Orphanet Journal of Rare Diseases|June 13, 2025
Validation of the self-report quantified Tuberous Sclerosis Complex-Associated Neuropsyciatric Disorders Checklist (TAND-SQ)Nola Chambers, Tosca-Marie Heunis, Sugnet Gardner-Lubbe, et al.
Orphanet Journal of Rare Diseases|July 7, 2021
Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)Matthias Sauter, Elena Belousova, Mirjana P Benedik, et al.
Pageof 2